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Abstract
A boundary lubricant attaches and protects sliding bearing surfaces by preventing
interlocking asperity-asperity contact. Proteoglycan-4 (PRG4) is a boundary lubricant
found in the synovial fluid that provides chondroprotection to articular surfaces.
Inflammation of the diarthrodial joint modulates local PRG4 concentration. Thus, we
measured the effects of inflammation, with Interkeukin-1α (IL-1α) incubation, upon
boundary lubrication and PRG4 expression in bovine cartilage explants. We further
aimed to determine whether the addition of exogenous human recombinant PRG4
(rhPRG4) could mitigate the effects of inflammation on boundary lubrication and PRG4
expression in vitro.
Cartilage explants, following a 7-day incubation with IL-1α, were tested in a discon-disc configuration using either rhPRG4 or saline (PBS control) as a lubricant.
Following mechanical testing, explants were studied immunohistochemically or
underwent RNA extraction for RT-PCR. We found that static coefficient of friction
(COF) significantly decreased to 0.14 ±0.065 from 0.21 ±0.059 (p=0.014) in IL-1α
stimulated explants lubricated with rhPRG4, as compared to PBS. PRG4 expression was
significantly up regulated from 30.8 ± 19 copies in control explants lubricated with PBS
to 3330 ± 1760 copies in control explants lubricated with rhPRG4 (p<0.001). Explants
stimulated with IL-1α displayed no increase in PRG4 expression upon lubrication with
rhPRG4, but with PBS as the lubricant, IL-1α stimulation significantly increased PRG4
expression compared to the control condition from 30.8 ± 19 copies to 401 ± 340 copies
(p=0.015). Overall, these data suggest that exogenous rhPRG4 may provide a therapeutic
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option for reducing friction in transient inflammatory conditions and increasing PRG4
expression. This article is protected by copyright. All rights reserved
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Introduction
Osteoarthritis (OA) is a debilitating joint disease that affects 1 in 2 individuals by
the age of 85.1 Treatment includes symptomatic relief using nonsteroidal antiinflammatory drugs (NSAIDs), viscosupplementation, and ultimately arthroplasty. Joint
replacement surgery led to $28.5 billion of hospitalization expenditures in 2009 in the
United States2 and comprised 35% of total arthritis-related procedures requiring
hospitalization. 3 Post-traumatic osteoarthritis (PTOA) encompasses 12% of the OA case
burden,4 and is suspected to involve mechanical, biological, and environmental causes
which together initiate and exacerbate cartilage degeneration.5 Inflammation following
joint trauma creates a nidus for the development of PTOA.6 Interleukin-1 (IL-1) is one
among many cytokines involved in joint inflammation.7 The importance of IL-1 in the
initiation and progression of OA is reflected by the clinical interest of insoluble IL-1
antagonists.8
Proteoglycan-4 (PRG4), also referred to as lubricin, is a large, mucinous
glycoprotein that coats the articular surfaces and provides articular cartilage boundary
lubrication during high load and slow sliding speeds9. IL-1α and inflammation in general
modulate PRG4 expression by synoviocytes as well as superficial and intermediate zone
chondrocytes.10 The N-terminus of PRG4 creates a disulfide bond between PRG4
monomers, enabling PRG4 to form a multilayer molecular film along the articular
surface.11 Hydration forces provided by O-linked mucin domain glycosylations are also
likely involved in repulsion of molecules, since removal of distal NeuAc (sialic acid) and
penultimate Gal (galactose) decreases lubricating ability in vitro.12 Under conditions of
reciprocating cyclic motion, boundary lubricants must be replenished to prevent articular
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wear.13 Recently a link between elevated coefficient of friction (COF), increased
mechanical strain, and increased chondrocyte caspase-3 activation in the absence of
inflammation has been established both in vitro and in vivo in animal models lacking
normal PRG4 lubrication.13; 14
These observations coupled with the well-known catabolic effects resulting from
mechanical injuries due to inflammatory mediators, such as IL-1, have initiated new
inquiry into the anabolic role that PRG4 plays in the protection of articular
chondrocytes.15; 16 Downstream catabolic effects of IL-1 include stimulation of matrix
metalloproteinase (MMP) production, increased proteoglycan release, and increased
cartilage matrix degradation, which may initiate the phenomenon of PTOA.17 These same
metabolic dyscrasias are also accompanied by synovitis in OA.18 Overexpression of IL1β in rabbits results in cellular hyperplasia, articular cartilage loss, and clinical
synovitis.19 Isolated bovine and rat chondrocytes treated with IL-1α showed decreased
PRG4 secretion and decreased PRG4 expression.20; 21 IL-1β has also been shown to
down-regulate PRG4 expression in chondrocytes.20-22 However, other studies suggest that
inflammation increases PRG4 production.23-25 Whether exogenous PRG4 can attenuate
the impact of IL-1 stimulation on native PRG4 expression by cartilage has not yet been
reported.
PRG4 supplementation has been shown to improve the diminished lubricating
ability of osteoarthritic, human synovial fluid.26 In rodent PTOA models, following either
meniscectomy27 or anterior-cruciate ligament transection (ACLT),28-30 the intra-articular
dosing of PRG4 has demonstrated improved histology,27-30 increased cartilage
thickness,30 and preservation of glycosaminoglycan compared to untreated controls.28; 29
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Rats under forced exercise, in particular, showed greater damage without PRG4
supplementation following ACLT.29 Additionally, Teeple et al. showed some
radiographic improvement following PRG4 supplementation in post-ACLT rat knees.30
Either recombinant human PRG4 (rhPRG4) or purified human synovial fluid PRG4 was
used in the aforementioned studies. The half-life of rhPRG4 is short, following intraarticular PRG4 administration.31 Thus, chondroprotective effects likely involve native
expression of PRG4 to support these observations.7; 29; 31; 32 We aimed to determine the
effects of IL-1α on boundary lubrication and its biological impact on PRG4 expression in
a cartilage-on-cartilage bovine explant model.14 We posited that the posterior area of the
femoral condyle, with less extractable PRG4, would be more susceptible to increases in
friction due to IL-1α stimulation.33 We further aimed to determine whether the addition
of exogenous rhPRG4 could mitigate the effects of inflammation on boundary lubrication
and PRG4 expression in vitro. We hypothesized that IL-1α stimulation of articular
cartilage explants will induce cartilage catabolism, leading to a decrease in PRG4
expression and an increase in COF. Furthermore, we hypothesized that the introduction
of rhPRG4, as a boundary lubricant, will have a restorative effect on cartilage through
increasing chondrocyte native PRG4 expression and decreasing COF in IL-1α treated
explants.
Materials Methods
Explant Harvest and Culture
Osteochondral explant pairs, 6 and 12mm in diameter, were cored from bovine femoral
condyles within 4 hours of slaughter. Explants intended for both friction and
immunohistochemical staining were acquired from 99 explants (79 mechanically
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stimulated, 20 controls) collected from 20 bovine femoral condyles from 20 adult steers
between the ages of 12-16 months. Cartilage surfaces that appeared grossly deformed or
damaged were rejected. Explant pairs were harvested from the anterior, mid, and
posterior regions of the medial femoral condyle (Figure 1). A separate group of explants
consisting of 12 explants harvested from 3 bovine femoral condyles from 3 donors was
used for PRG4 expression evaluation. Another group of explants, consisting of twenty
12mm explants and ten 6mm and 12mm explant pairs, was harvested from 5 bovine
femoral condyles from 5 donors and used for dual imaging of native PRG4 and
exogenous rhPRG4. All osteochondral explant groups were harvested from the medial
region of the femoral condyle. Explant pairs underwent three washes with 5 ml of
Dulbeccos Modified Eagles Medium containing 4.5g/L D-glucose and L-glutamine
(DMEM) from (Gibco by Life Technologies) and centrifugation at 2500 rpm for 5
minutes. Explants were then cultured for 7 days in the same DMEM containing 10% fetal
bovine serum (Hyclone GE Life Sciences) and 1% penicillin streptomycin containing
5,000 units/ml penicillin and 5,000 µg/ml streptomycin (Gibco by Life Technologies)14
either with or without recombinant IL-1α at a concentration of 10 ng/ml in PBS (R&D
Systems Inc., Minneapolis, MN).14; 22 Medium containing IL-1α was changed at days 3
and 5 and new medium containing IL-1α was added.
Manufacture and Purification of rhPRG4
The expression of rhPRG4 by CHO-M cells has been described previously.34 CHO-M
cells were transfected with the full-length human PRG4 gene resulting in a full-length
PRG4 (1404 amino acids in length). The presence of O-linked glycosylations comprised
of (β1,3)Gal-GalNAc was previously confirmed by mass spectrometry.35
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Mechanical Stimulation Methodology
Explant pairs lubricated with 100μl of either phosphate-buffered saline (PBS) or rhPRG4
(Lubris, LLC, Framingham, MA) from a stock solution of 1mg/ml in PBS were mounted
into a materials testing system (BOSE Electroforce 3200; Prairie Eden, MN). Mechanical
stimulation of opposing explant pairs was preceded by 12N static compression for 8
minutes, resulting in approximately 18% compressive strain. This interval allowed the
pore pressure to depressurize within the cartilage samples to approximate towards zero.
After depressurization, the explant pairs underwent 12 cycles of ±720˚rotation while
under constant axial strain. Static COF, a measure of the stick-slip condition, and
dynamic COF (equilibrium COF) were calculated from the torque and axial load
measured during the rotation sequence. The following equations were used:
1) Static COF= Tmax/(2/3∗𝑅∗Feq)
2) Dynamic COF= Tave/(2/3∗𝑅∗Feq)
where Tmax= torque max within the first 20˚ of rotation, Tavg=torque average for the last
720˚ of rotation, R=radius of the 6 mm explant, and Feq=equilibrium force obtained after
cartilage decompression.14
Digital calipers were used to measure the initial total cartilage thickness values of
the 12mm and 6mm explant bearing pairs. Four caliper values were measured and
averaged for each explant in the pair and the total cartilage thickness was determined as
the sum of the averaged explant thickness values forming the explant pair. Total cartilage
thickness values were 1.48 ±0.398 mm for the 6mm explants, 1.28±0.274 mm for the 12
mm explants, and 2.76± 0.609 mm for total cartilage thickness of all explant pairs. The
total cartilage thickness of an explant pair was compared to the change in measured
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displacement across these two cartilage surfaces after mechanical loading had occurred.
This comparison yielded a change in cartilage thickness for each of the explant pairs.
Explant pairs with apparent compressive strains of 10% or less, or 30% or more were
excluded. Secondly, if the standard deviation for the equilibrium force (Feq) within
explant pairs harvested from the same knee joint was 0.5 or greater, explant pairs whose
Feq were less than 2N, were excluded. These two criteria were used to minimize the
impact of outliers on variability in COF, attributable in our experience, to abnormal
specimen variability, inadequate mounting, and confounders caused by geometry of two
surfaces that are not normally apposed or parallel to one another. Of the 79 explant pairs
mechanically tested, 17 were excluded. Nominal Feq for the accepted explants was
2.84±0.622 N. Data points used for the COF statistical analysis within each mechanical
testing subset from the anterior, mid, and posterior region respectively for the 79 explants
taken from 20 bovine femoral condyles are as follows: Control-PBS (n=5, n=6, n=3); IL1-PBS (n=4, n=6, n=3); Control-rhPRG4 (n=6, n=9, n=4); IL-1-rhPRG4 (n=4, n=6, n=6).
Histology Preparation
After COF measurement, the 12mm explants from each testing pair were placed in
formalin, decalcified with EDTA, and sectioned into 10µm thick sections. PRG4
accumulation was determined from 62 explant pairs. PRG4 accumulation was visualized
in these samples and the 20 non-mechanically stimulated 12mm explant controls.
Monoclonal antibody 9G3 (EMD Millipore; Darmstadt, Germany), which reacts with an
epitope in the mucin domain of PRG4, was used to visualize PRG4 accumulation.36
Control explants for each treatment group were immediately placed in formalin after 7
days of culture and not exposed to lubricant supplementation or mechanical stimulation.
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Real Time Polymerase Chain Reaction (RT-PCR)
The second group of 12 explants from 3 donors was cultured with or without
10ng/ml of IL-1α for 7 days. Each of 4 explant pairs harvested from each bovine femoral
condyle was assigned a different experimental group (either IL-PBS, IL-rhPRG4,
Control-PBS, or Control-rhPRG4). Immediately after testing, the cartilage section of the
osteochondral explant was separated from the bone. Cartilage samples were placed in an
RNA preservation solution (RNAlater, Thermo Scientific) and stored at -80C until RNA
isolation was performed. Three RNA samples were obtained for each of the 4 explant test
groups. These three RNA samples were then pooled and evaluated in triplicate by RTPCR.
Cartilage was minced with a #15 scalpel blade for RNA extraction. The RNA
storage solution was carefully removed, and cartilage pieces were moved into 2ml lysing
matrix tubes (MP Biomedical) to which 700μl QIAzol lysis buffer (QIAGEN, GmbH,D
Hilden, Germany) was pipetted. The cartilage specimens were homogenized 10 times for
15 seconds, with 2 minutes of rest in ice between subsequent 15-second homogenization
cycles (MP FastPrep-24 homogenizer MP Biomedicals, LLC. Santa Ana, CA). Total
RNA was extracted and purified using miRNeasy micro kit (QIAGEN, GmbH,D Hilden,
Germany) according to the manufacturer's protocol. The concentration of eluted RNA
was determined via NanoDrop software (Thermo Scientific). cDNA was synthesized
from 5 μg of total RNA. RT-PCR performed on a Mastercycler Realplex4 (Eppendorf
North America) system using qPCR Kit Kapa Sybr fast master mix (Kapabiosystems,
Boston, MA, USA) and under conditions recommended by these manufacturers. After
agarose gel analysis and purification of a 135 bp PCR product (QIAquick gel extraction
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kit.Qiagen Sciences, Germantown, MD), the DNA concentration was measured and a
standard curve was created based on dilution. The same was also accomplished for
glyceraldehyde 3-phosphate dehydrogenase (GAPDH).
Primer sequences for bovine PRG4 are as follows: Forward: 5ACTCCACCACCTCCACCTCGG -3, Reverse: 5- GCTGAACGCTGCCACCTCTC -3.
GAPDH was used as the internal control: Forward: 5AGGTCATCCATGACCACTTTGG -3; Reverse: 5-GCAGGTCAGATCCACAACAG3. The standard or sample volumes were 20 µl per reaction. qPCR program for PRG4
was: 95° C for 15 min, then 95°C 15 sec, 65°C 15 sec, 72°C 20 sec for 45 cycles. qPCR
program for GAPDH was: 95°C for 15 min, then 95°C 15 sec, 55°C 15 sec, 72°C 20 sec
for 45 cycles. The expression levels (number of copies) were normalized to GAPDH
levels. PRG4 copy number was obtained from a standard curve with 100% efficiency.
Sample copy number was expressed as number of copies of PRG4 per 100 copies of
GAPDH.
Dual Imaging of rhPRG4 and Native PRG4
The third group of explants, described above, was harvested for PRG4 dual imaging of
rhPRG4 and resident bovine PRG4. This group of explants consisted of twenty 12mm
explants that were not mechanically stimulated and ten 6mm and 12mm explant pairs that
were mechanically stimulated. These explants were harvested from 5 bovine femoral
condyles from 5 donors and cultured with or without 10ng/ml of IL-1α for 7 days. Each
of the four 12 mm explants and two 6mm and 12mm explant pairs harvested from each
bovine femoral condyle were assigned to a different non-mechanical (IL-rhPRG4, IL,
Control-rhPRG4, or Control) or mechanical (IL-rhPRG4 or Control-rhPRG4) testing
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group. rhPRG4 was labeled using a Pierce NHS-rhodamine antibody labeling kit
(Thermo Fisher Scientific; Grand Island, NY) according to manufacturer instructions
using a 2mg/ml concentration of rhPRG4. Explants were then exposed to 100μl of PBS
or rhPRG4-rhodamine as a lubricant for 15 minutes with and without mechanical
stimulation using the mechanical stimulation protocol described above. Cartilage was
removed from bone immediately after experimentation and frozen at -80˚C. Sections of
frozen cartilage were then cut and stained with 9G3 and DAPI before being imaged. Two
sections of cartilage were stained and imaged per sample with 5 samples evaluated per
test group.
Statistical Analysis
Three-way analyses of variance (ANOVA) were used to determine the effects of
lubricant (PBS vs. rhPRG4), IL-1α incubation condition (IL-1α treated vs. control), and
cartilage harvest region (anterior, mid, and posterior) on static and dynamic COF values
in mechanically stimulated bovine cartilage explants. Lubricant and IL-1α incubation
condition were across-subject factors and harvest region was a within-subject factor in
the model. If significant interactions were detected, partial F-tests were used post hoc to
test simple effects (e.g. lubricant effect within IL-1α incubation condition or IL-1α effect
within lubricant). Similarly, a two-way ANOVA followed by partial F-tests were used to
determine the effects of the lubricant and IL-1α incubation condition on PRG4 expression
assayed via RT-PCR. Because RT-PCR data was log transformed prior to analysis,
geometric means and their associated standard errors are presented. All analyses were
performed using SAS Version 9.4 (SAS Institute, Cary, NC). Statistical significance
determined based on p < 0.05.
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Results
Application of rhPRG4 to Cartilage Explants Stimulated with IL-1 Restores Low Friction
PRG4 accumulation at the articular surface (Figure 2) was qualitatively diminished in IL1α treated, non-mechanically stimulated explants (IL) compared to their IL-1α free, nonmechanically stimulated counterparts (Control). The lack of PRG4 accumulation at the
articular surface of IL-1α stimulated explants was restored upon lubrication with rhPRG4
but diminished upon lubrication with PBS (Figure 2). These qualitative observations in
PRG4 surface accumulation parallel the static COF data in Figure 3a, where explants
with decreased PRG4 available at the articular surface demonstrated higher static COF.
Three-way analysis of variance results indicate that the effect of lubricant on static COF
values was dependent upon whether or not IL-1α was present (lubricant by IL-1α
condition interaction, p=0.022). IL-1α treated explants lubricated with PBS during
mechanical stimulation displayed significantly higher static COF values compared to IL1α free explants lubricated with PBS (p=0.02). No significant difference was observed
between IL-1α conditions in rhPRG4 lubricated explants (p=0.37). Additionally, IL-1α
treated, rhPRG4 lubricated explants displayed significantly lower static COF compared to
IL-1α treated, PBS lubricated explants (p=0.014). The significantly lower mean static
COF (0.14 ±0.065) for IL-1α treated, rhPRG4 lubricated explants compared to the mean
static COF (0.21 ±0.059) for IL-1α treated, PBS lubricated explants indicates that
rhPRG4 has the ability to increase boundary lubrication in IL-1α treated explants. Mean
static COF (0.16 ±0.066) of IL-1α free explants lubricated with rhPRG4 and the static
COF (0.15 ±0.052) for IL-1α free explants lubricated with PBS were not significantly
different (p=0.44). Thus, residual PRG4 at the articular surface of IL-1α free explants

This article is protected by copyright. All rights reserved

was capable of compensating for the lack of lubrication provided by PBS and may
account for the lack of significant difference in friction values for IL-1α free explants
lubricated with rhPRG4 compared to lubrication with PBS (Figure 2).
When dynamic COF was examined, analyses of variance results indicated no
significant effect of lubricant (p=0.08), IL-1α incubation condition (p=0.90) nor any
evidence of an interaction (p=0.21).
Static and dynamic COF values separated by location from the anterior, mid, and
posterior regions of the femoral condyle are displayed in Figure 3B. Based on three-way
analyses of variance results, there was no evidence that static or dynamic COFs differed
across regions (p=0.26 and p=0.59, respectively), nor was their evidence that the effects
of lubricant and/or IL-1α incubation condition were region dependent (all interactions,
p’s > 0.10).
Labeled rhPRG4 Accumulates on the Articular Surface
Rhodamine labeled rhPRG4 was used to assess the extent to which rhPRG4 attached and
infiltrated the cartilage in IL-1α stimulated explants lubricated with rhPRG4 and IL-1α
free explants lubricated with rhPRG4. A greater amount of rhodamine labeled rhPRG4
was observed in the cartilage of IL-1α stimulated explants compared to IL-1α free
controls (Figure 4). It appeared that rhPRG4 markedly accumulated on the cartilage
surface.
Restoration of PRG4 Expression via rhPRG4 in IL-1α Stimulated Cartilage Explants
Based on the two-way analysis of variance, there was a significant interaction between
lubricant and IL-1α incubation condition on PRG4 expression (p=0.006). PRG4
expression was significantly up regulated from 30.8 ± 19 copies in IL-1α free explants
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lubricated with PBS to 3330 ± 1760 copies in IL-1α free explants lubricated with rhPRG4
(p<0.001)(Figure 5). These data indicate that rhPRG4 significantly increases native
PRG4 expression in cartilage explants undergoing mechanical stimulation when not
exposed to inflammation. Explants stimulated with IL-1α did not respond in this manner.
There was a significant increase in PRG4 expression from 30.8 ± 19 copies in IL-1α free
explants lubricated with PBS to 401 ± 340 copies in IL-1α stimulated explants lubricated
with PBS (p=0.015). Conversely, explants stimulated with IL-1α and lubricated with
rhPRG4 trended toward significantly decreased PRG4 expression from 3330 ± 1760
copies in IL-1α free explants lubricated with rhPRG4 to 525 ± 41.2 copies (p=0.057).
Discussion
This study indicated that IL-1α stimulation of bovine cartilage explants resulted in
significantly increased static COF under lubrication with PBS and that rhPRG4 was
capable of significantly lowering increased COF under this inflammatory condition in
vitro. Furthermore, we showed that in the IL-1α free condition PRG4 expression is
significantly up regulated with use of rhPRG4 as a lubricant and that the effect of IL-1α
stimulation on PRG4 expression compared to the IL-1α free condition is lubricant
dependent under mechanical stimulation. However, we did not observe the same findings
upon analyzing explants separately from the anterior, mid, and posterior regions of the
femoral condyle. This is perhaps due to small regional sample size numbers, especially in
the posterior region, which partly occurred as a result of our exclusion criteria. This
observation must be reconciled with other studies that showed explants from the anterior
femoral condyle contained greater extractable amounts of PRG4 compared to explants
from the posterior area.33; 37
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Recently, Peng et al found significant differences in equilibrium COF between the
anterior-most and posterior-most cartilage regions of the femoral condyle in a pin-on-disc
tribological system with cartilage harvested from calves.37 Our present study evaluated
static and dynamic COF in the anterior, mid, and posterior regions of the femoral condyle
using a cartilage disc-on-cartilage disc set up with explants harvested from skeletally
mature adult steers. Peng et al only allowed for 2 minutes of cartilage depressurization
following a 0.1 MPa load and performed studies at a 0.5 mm/s sliding speed, which is
faster than commonly used in other tribological studies.38-41 Our present work used 8
minutes of depressurization following a 0.42 MPa load and a 0.3mm/s sliding speed
coupled with rigorous exclusion criteria.
Immunohistochemistry confirmed that rhodamine-labeled rhPRG4 attached to the
cartilage surface, possibly infiltrated the superficial zone, and provided a surface coating
that recapitulates native PRG4, particularly in the IL-1α stimulated explants. This
rhPRG4 coating acted as an anti-adhesive and lubricating physisorbed layer that
diminished both static and dynamic friction in IL-1α stimulated, bovine cartilage
explants. These in vitro inflamed explants showed little to no residual, native PRG4 at the
cartilage surface. Thus, the significant reduction in dynamic and static friction between
IL-1α stimulated explants lubricated with saline compared to IL-1α stimulated explants
lubricated with rhPRG4 was due to the restoration of boundary lubrication by the
addition of exogenous rhPRG4. Also, the lack of a statistically significant difference in
friction between IL-1α stimulated explants lubricated with rhPRG4 and IL-1α free
explants lubricated with saline indicates that rhPRG4 may be lubricating just as
effectively as the naturally expressed residual bovine PRG4 found on IL-1α free explants.
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The exact mechanism by which IL-1α removes PRG4 from the surface has yet to be fully
determined. However, we posit that the combination of PRG4 down regulation by IL-1α,
along with increased MMP production in IL-1α exposed cartilage,17 promotes the
removal of PRG4 from the cartilage surface.
Our current work indicates that exogenous rhPRG4 and, thus perhaps, synovial
PRG4 have mechanobiological effects. The articular surface of IL-1α free cartilage relubricated by rhPRG4 resulted in more native PRG4 expression. The mechanism through
which rhPRG4 up regulates native PRG4 expression has yet to be fully elucidated.
However, prior reports describe that the combination of load and lubricated mechanical
sliding increases PRG4 expression.42; 43 The up regulation of PRG4 expression in IL-1α
stimulated explants evidently depends upon the lubricant used. PBS as the lubricant led to
an increase in PRG4 expression, whereas rhPRG4 as the lubricant may have led to a
decrease in PRG4 expression. Overall, the IL-1α stimulation appeared to interfere with
the normal mechanobiological response of cartilage to the combination of load and
lubricated mechanical sliding. These results also support PRG4’s role as the primary
boundary lubricant in synovial fluid since neither HA nor surface-active phospholipids
were added. Overall, HA may play a synergistic role with PRG4 in lowering COF,39 but
the role phospholipids play in boundary lubrication is unclear.44-47 In regards to whether
or not PRG4 has a direct anti-inflammatory effect, a recent study showed that PRG4
competes with HA in binding CD44, and initiating an anti-inflammatory response.48
Intra-articular delivery of rhPRG4 may be therapeutically applicable to other
forms of joint inflammation as well. Indeed, human synovial fluid samples from patients
with OA and RA patients,49 as well as menisci from OA patients,50 have been shown to
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contain decreased PRG4 compared to control samples. In other work, human RA tissue
samples from patients with advanced disease progression displayed significantly
decreased PRG4 expression compared to control samples.51
Prior studies indicate that PRG4 protein levels are decreased with inflammation,20;
52; 53

and that PRG4 mRNA expression is down regulated.21; 22; 54 However, PRG4 levels

were increased at certain time-points in models of PTOA.23-25 Quantification of PRG4
using ELISA and Western blot carry the limitations inherent in the anti-PRG4 antibodies
currently available. These antibodies detect either a terminal end of the PRG4 protein or
the glycosylated mucin domain.36 Thus, PRG4 protein fragments, generated by increased
proteolytic activity in inflammatory conditions, may have been detected and reported in
lieu of intact PRG4 protein in these previous studies.
Limitations of this study include that bovine cartilage samples were obtained from
specimens of varying ages and only from the medial femoral condyles of the animals. We
had greater consistency in harvesting from a curved surface like the femoral condyle but
this also creates the limitation of not having a paired tibial plateau cartilage surface. Only
8 minutes for cartilage depressurization was allowed in order to maintain cartilage
viability during friction testing to enable subsequent immunohistology and RNA
isolation. Eight minutes approximates a majority of the depressurization but is not
maximal.55 However, the equilibrium loads used in this study were similar to prior
tribological studies.56 Additionally, the cartilage explant bearings in this study were
cultured to maintain cell viability and only mechanically stimulated once. This enabled us
to determine the mechanical, cartilage-on-cartilage, frictional effects as well as the
biological effects of IL-1α stimulation on protein expression in chondrocytes for the 12
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mm explant from each explant pair. A gimbal system57; 58 was not in place in our test
system to maintain perfect co-planarity as the two oscillating cartilage surfaces moved
past one another during the friction tests. Thus variations in friction caused by surface
imperfections or imprecise mounting could also cause a sporadic increase in friction,
which is why criteria were established for acceptability of the data.
Conclusions
Exogenous rhPRG4 significantly reduced static friction values for IL-1α
stimulated, bovine cartilage explants. Immunohistochemistry for PRG4 showed removal
of PRG4 from the cartilage surface during IL-1 stimulation. This PRG4 deficiency at the
surface was restored upon addition of rhPRG4 as a lubricant. Additionally, IL-1α free
cartilage explants showed significantly increased PRG4 expression when lubricated with
rhPRG4 compared to saline. IL-1 alters the normal mechanobiological response of
cartilage to the combination of load and lubricated mechanical sliding.
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Figure Legends
Figure 1: Diagram demonstrating methods of explant harvest, preparation, and mechanical
stimulation of bovine cartilage explant pairs. Panel A displays the medial femoral condylar
region of the bovine knee from which 12 and 6mm explant pairs were harvested from the
anterior, mid, and posterior regions. Panel B displays the two groups of explant pairs incubated in
culture medium supplemented with or without IL-1α for 7-days following explant pair harvest.
Panel C shows the explant pairs with their intervening test lubricants. Panel D displays the
mechanical stimulation set up including explant pair mounting to the machine components using
ethyl cyanoacrylate glue, the magnitude and direction of the load applied to the explant pairs, and
the platform rotation from which torque values were obtained for COF calculation.

Figure 2: PRG4 Immunohistochemistry. Immunohistological detection of PRG4 by 9g3
(green) and cell nuclei via DAPI (blue) in non-mechanically stimulated (-Mechanical) and
mechanically stimulated (+Mechanical) bovine cartilage explants cultured with IL-1α (+IL-1α,
IL) or IL-1α free media (-IL-1α, Control) is shown in six representative images. Either phosphate
buffered saline (PBS) or recombinant PRG4 (rhPRG4) was used as a lubricant for mechanically
stimulated explants. IL-1α treated, non-mechanically stimulated explants (n=20) displayed
decreased PRG4 compared to control treated, non-mechanically stimulated explants (Control,
n=20). IL-PBS explants (n=13) displayed no change in PRG4 while IL-rhPRG4 explants (n=16)
displayed increased PRG4 on the surface comparable to Control explants and Control-rhPRG4
explants (n=19). Control-PBS explants (n=14) displayed marked decrease in PRG4 compared to
Control and Control-rhPRG4 explants. Scale bar is 50 microns.

Figure 3: (A) Total COF Across Cartilage Explant Groups. Dynamic (right) and static (left)
coefficient of friction (COF) data for mechanically stimulated, IL-1α supplemented (IL, gray) or
IL-1α free (Control, black) explants lubricated with either phosphate buffered saline (PBS, left) or
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recombinant PRG4 (rhPRG4, right) are illustrated above. IL-PBS explants (n=13) displayed
significantly higher static COF compared to Control-PBS explants (n=14, *p=0.02) IL-PBS
explants also displayed significantly higher static COF compared to IL-rhPRG4 explants (n=16,
*p=0.014). Values represented as mean ± standard deviation.
(B) COF by Cartilage Region. Dynamic (right) and static (left) COF of the anterior, mid and
posterior areas of the medial femoral condyle is shown. No significant difference was found for
static and dynamic COF by cartilage region.

Figure 4: Immunohistochemistry of PRG4 in the Presence of Exogenous Rhodamine
Labeled rhPRG4. Representative images showing exogenous rhPRG4 (red) and a combination
of exogenous and endogenous PRG4 for IL-1α treated (+IL-1α) and control (-IL-1α) explants
with (+rhPRG4) or without (-rhPRG4) rhodamine labeled rhPRG4. Green indicates detection of
all PRG4 present by 9g3(whether endogenous or exogenous) and red indicates exogenous,
rhodamine-labeled rhPRG4. Counter staining of cell nuclei with DAPI is blue. Samples lubricated
with rhPRG4 were either mechanically stimulated (+Mechanical) or not mechanically stimulated
(-Mechanical). IL-1α stimulated explants without rhPRG4 (n=5) exhibited little to no endogenous
PRG4, while IL-1α stimulated samples with rhPRG4 (n=5) displayed greater amounts of
exogenous rhPRG4 penetrating into the cartilage superficial zone. IL-1α stimulated samples
appear to exhibit more exogenous rhPRG4 attachment than their IL-1α free counterparts (n=5).
This suggests that IL-1α stimulation diminishes endogenous PRG4 while allowing for increased
exogenous rhPRG4 attachment and penetration into the cartilage tissue. Scale bar is 100 microns.

Figure 5: PRG4 mRNA Expression Across Cartilage Explant Groups PRG4 mRNA for
mechanically stimulated bovine cartilage explants cultured with IL-1α supplemented medium (IL,
gray) or IL-1α free medium (Control, black) is shown above. Either phosphate buffered saline
(PBS) or recombinant PRG4 (rhPRG4) was used as a lubricant during mechanical stimulation.
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PRG4 expression was significantly up regulated from 30.8 ± 19 copies in control explants
lubricated with PBS to 3330 ± 1760 copies in control explants lubricated with rhPRG4 (n=3,
p<0.001). PRG4 expression significantly increased from 30.8 ± 19 copies in IL-1α free explants
lubricated with PBS to 401 ± 340 copies in IL-1α stimulated explants lubricated with PBS (n=3,
p=0.015). Explants stimulated with IL-1α and lubricated with rhPRG4 trended toward
significantly decreased PRG4 expression from 3330 ± 1760 copies in IL-1α free explants
lubricated with rhPRG4 to 525 ± 41.2 copies (n=3, p=0.057). Values represented as geometric
mean ± standard error.
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